Emergent BioSolutions Inc. has entered into an agreement to invest in Swiss Rockets Ltd, supporting research, infrastructure expansion, and biotech innovation. Swiss Rockets is the parent company of Rocketvax Ltd, a Swiss-based next-generation vaccine developer. The investment aligns with Emergent’s strategy to
Emergent BioSolutions, a leading biopharmaceutical company, has announced an exclusive six-year agreement with Hikma Pharmaceuticals to distribute KLOXXADO Nasal Spray in the United States and Canada. This high-dose, 8 mg naloxone hydrochloride spray is approved for emergency treatment of known
Just two months into his role as CEO at Emergent BioSolutions, Joseph Papa has announced a significant organisational restructuring for the company. This restructuring involves a workforce reduction of about 300 employees across all areas of the company and the closure
Emergent BioSolutions is a Manufacturer/Innovator company operating in the pharmaceutical industry. Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent has been a go-to source for solving some of the
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
